Tarantula venom could offer relief from irritable bowel syndrome
A specific peptide in spider venom could be used to understand how people sense pain
Author
Polaris Group reports phase III study results of ADI-PEG 20 plus best supportive care in advanced…
The full study results were presented at ASCO's 2016 annual meeting in Chicago
Tanaz Buhariwalla to head IDA Ireland’s India business
India team to double number of Indian investments into Ireland by 2020
New merger between Pfizer and Anacor to leverage opportunities in atopic dermatitis space:…
The severe atopic dermatitis market is set to be a difficult one for new entrants to penetrate
Pharma M&As: value creator or value destroyer?
Anil Khanna, Partner, Tai Pi Advisors analyses the trend of rising M&As in the pharma industry and examines its causes and…
Meningococcal vaccines market set to approach $1.8 bn by 2025: GlobalData
The provision of a single vaccine that can protect the population against all prevalent serogroups is the most important…
Frost & Sullivan study identifies top ten technologies transforming health and wellness
Provides trends, insights, and technologies of focus for stakeholders in this segment and the emerging market needs that are…
BIRAC, BMGF and IKP collaborate for GCE-India programme, call for proposals
GCE-India to seek innovative solutions in drug delivery systems, diagnostics, and technology enabled service models and medical…
PatientSafe India to address the challenge of drug counterfeiting
The conference, to be held on June 28, 2016 at Courtyard Marriott, Mumbai, will deliberate on creative ways to raise awareness and…
Express Pharma (Vol.11, No.16) June 16-30, 2016
India's Foremost Pharma & Biotech Magazine